1 week Ago
CytomX Therapeutics, Inc. ( NASDAQ: CTMX ) Q1 2024 Results Conference Call May 8, 2024 5:00 PM ET Company Participants Chris Ogden - Senior Vice President, Finance and Accounting Sean McCarthy - Chief Executive Officer and Chairman Wayne Chu - Chief Medical Officer Conference Call Participants Peter Lawson - Barclays Roger Song - Jefferies Joe Catanzaro - Piper Sandler Etzer Darout - BMO Capital Markets Anupam Rama - JPMorgan Mitchell Kapoor - H. C.
Wainwright Operator Good day, and thank you for standing by. Welcome to the CytomX Therapeutics First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen only-mode.
After the speaker's presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that, today's conference is being recorded. I would now like to turn the conference over to your speaker today, Chris Ogden, CytomX's Senior Vice President, Finance and Accounting.
Please go ahead. Chris Ogden Thank you. Good afternoon and thank you for joining us.
Before we begin, I would like to remind everyone that, during this call, we will be making forward-looking statements. Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict and many of which are outside of our control. Important risks and uncertainties are set forth in our most recent public filings with the SEC at sec.
gov. We undertake no obligation to update any.
